These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21889898)

  • 1. Detection of a fatty liver after binge drinking: correlation of MR-spectroscopy, DECT, biochemistry and histology in a rat model.
    Korkusuz H; Keese D; Raschidi BA; Hübner F; Namgaladze D; Hintereder G; Hammerstingl R; Korkusuz Y; Mönch C; Vogl TJ
    Acad Radiol; 2011 Nov; 18(11):1349-57. PubMed ID: 21889898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy.
    Marsman HA; van Werven JR; Nederveen AJ; Ten Kate FJ; Heger M; Stoker J; van Gulik TM
    J Magn Reson Imaging; 2010 Jul; 32(1):148-54. PubMed ID: 20578022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive quantification of triglyceride content in steatotic rat livers by (1)H-MRS: when water meets (too much) fat.
    Heger M; Marsman HA; Bezemer R; Cloos MA; van Golen RF; van Gulik TM
    Acad Radiol; 2011 Dec; 18(12):1582-92. PubMed ID: 22055799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing and quantification of acute alcohol intoxication--comparison of dual-energy CT with biochemical analysis: initial experience.
    Korkusuz H; Abbas Raschidi B; Keese D; Namgaladze D; Kromen W; Bauer RW; Vogl TJ
    Rofo; 2012 Dec; 184(12):1126-30. PubMed ID: 22847018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of intrahepatic triglyceride stores by 1H magnetic resonance spectroscopy: study with rat models and in patients].
    Liu M; Gao X; Rao SX; Wu L; Zeng MS
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):531-3. PubMed ID: 18649768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T ¹H-magnetic resonance spectroscopy.
    Ou HY; Chao PH; Yu PC; Wei YC; Chen CL; Yu CY; Chiu TM; Chang YC; Lai CY; Cheng YF
    Transplant Proc; 2012 May; 44(4):955-8. PubMed ID: 22564595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of liver triglyceride levels with 3T ¹H-MR spectroscopy in mice with moderately elevated liver fat content.
    Runge JH; Bakker PJ; Gaemers IC; Verheij J; Hakvoort TB; Ottenhoff R; Stoker J; Nederveen AJ
    Acad Radiol; 2014 Nov; 21(11):1446-54. PubMed ID: 25300722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.
    Mitchell DG; Kim I; Chang TS; Vinitski S; Consigny PM; Saponaro SA; Ehrlich SM; Rifkin MD; Rubin R
    Invest Radiol; 1991 Dec; 26(12):1041-52. PubMed ID: 1765436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of electron beam computed tomography for coronary artery calcium screening to evaluate fatty liver: comparison with 1H magnetic resonance spectroscopy in the Dallas Heart Study.
    Matulevicius S; Huff LC; Szczepaniak LS; Ayers CR; Budoff M; McColl R; Khera A; Peshock RM
    J Investig Med; 2011 Jun; 59(5):780-6. PubMed ID: 21441828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.
    Keese D; Korkusuz H; Huebner F; Namgaladze D; Raschidi B; Vogl TJ
    Diagn Interv Radiol; 2016; 22(1):13-21. PubMed ID: 26627137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hepatic steatosis using dual-energy CT with MR comparison.
    Sun T; Lin X; Chen K
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1377-85. PubMed ID: 24896357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of the most powerful predictors for the evaluation of hepatic steatosis grade: an experimental study.
    Su ZZ; Shan H; He BJ; Lv WT; Meng XC; Wang J; Zhu KS; Yang Y; Chen GH
    Eur J Radiol; 2009 Oct; 72(1):118-24. PubMed ID: 18653298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduced insulin effect in subclinical fatty liver].
    Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
    Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
    Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C
    J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Zhong L; Chen JJ; Chen J; Li L; Lin ZQ; Wang WJ; Xu JR
    J Dig Dis; 2009 Nov; 10(4):315-20. PubMed ID: 19906112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.